IFEBP survey: employers covering GLP-1s for both diabetes and weight loss
Metric EN-08 · Series EN: Employer Innovation
IFEBP survey: employers covering GLP-1s for both diabetes and weight loss was 36% in 2025, according to International Foundation of Employee Benefit Plans survey.
This figure is reported as Metric EN-08 in The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report (James M. Knox, DOI: 10.5281/zenodo.22772957).
Definition
This metric measures ifebp survey: employers covering glp-1s for both diabetes and weight loss among international foundation of employee benefit plans survey respondents. The unit of measurement is percent of respondents. The geographic scope is United States.
Current Value
| Value | Data Year | Population | Geography |
|---|---|---|---|
| 36% | 2025 | International Foundation of Employee Benefit Plans survey respondents | United States |
Source
International Foundation of Employee Benefit Plans survey.
Methodological Notes
This figure is drawn from International Foundation of Employee Benefit Plans survey. Where a second source reports a different figure for the same condition, both values and the reason for the discrepancy are documented in the report rather than reconciled.
See Methodology and Sources for the full source selection criteria and conflict resolution approach.
Related Metrics
- EN-01Large employers likely to continue GLP-1 coverage in 2027 (BGH survey)
- EN-02Large employers unlikely to continue GLP-1 coverage in 2027 (BGH survey)
- EN-03Large employers intending to maintain GLP-1 coverage (WTW survey)
- EN-04Large employers likely or very likely to discontinue GLP-1 coverage (WTW)
- EN-05Large employers somewhat likely to discontinue GLP-1 coverage (WTW)
Cite This Metric
Last reviewed: October 2026